fbpx Skip to main content

Member Resources

Check this page for the latest information, guidance and updates from Biocom, public policy and our partners regarding the novel coronavirus (COVID-19) as it relates to California’s life science industry.

Policy Announcements  Business Continuity  Events & Resources

Policy Announcements

Statewide

Federal

Bay Area

  • March 31, 2020 Update: The six counties in the San Francisco Bay Area that initially issued shelter-in-place orders on March 16th extended and revised their orders with further restrictions, including limitations on construction activity. While pharmaceutical and biotechnology companies are still considered essential and may continue to operate as normal while practicing social distancing, construction will now be limited to: healthcare projects directly related to addressing the COVID-19 pandemic, housing and mixed use projects that include a minimum of 10% affordable units, projects that “provide services to vulnerable populations,” and developments that are required to “maintain the safety, sanitation, and habitability of residence and commercial buildings.” Alameda County | Contra Costa County | Marin County | San Francisco City and County | San Mateo County | Santa Clara County | City of Berkeley.

San Diego

Los Angeles

Orange County

Business Continuity

Updates on possible disruptions to the daily and future operations, travel and supply chains of our California life science members.

Supply Chain

Travel & Workplace

Laboratory

Environmental Health & Safety

  • OSI Sample Coronavirus Company Strategy
  • Emergency Response Plan
  • Note: Our local policy team has been actively connecting with key EH&S leaders throughout our member base. Some of Biocom’s key members have graciously shared internal documents that can be accessed through a password protected web portal. These are technical resources for Environmental Health & Safety professionals that are only appropriate to be shared within the EH&S community. In response to our members’ requests, we have limited access to the documents and they must be shared through this secured site. Please contact Melanie Cohn to request access or ask any Environmental Health & Safety-related questions.

Funding for COVID-19 Solutions

Events & Resources

Check back often for Biocom workshops and events that address evolving COVID-19 concerns, as well as any updates or possible cancelations of larger events and conferences. View our updated events policy here.

Regulatory Rundown: Week of March 9-13, 2020

Learn about key regulatory takeaways from recent coronavirus news and developments.

Read more

Coronavirus Roundtable: HHSA Response and Company Prevention Measures

How is your company preparing for and responding to the novel coronavirus (COVID-19)? Read takeaways from Biocom’s March 6th event that brought together industry Environmental Health & Safety managers from companies of all sizes in San Diego to discuss just that.

Read summary

Biocom Japan Updates:

  • Telecommuting and virtual meetings: As of March 1, 46% of companies in Japan are to some extent telecommuting or conducting meetings online. Many large companies will continue to telecommute through mid-March and reassess at that time.
  • Events: Many events are getting cancelled, including BioAsia (3/10-3/11), while some others being postponed. BioJapan, scheduled for October, is still taking place at this time. Members should remain in close contact with event organizers.